TREA

97881889 - BIOFLUCISION

Follow

Information

  • Trademark
  • 97881889
  • Serial Number
    97881889
  • Registration Number
    7600827
  • Filing Date
    April 10, 2023
    2 years ago
  • Registration Date
    December 10, 2024
    a year ago
  • Transaction Date
    December 10, 2024
    a year ago
  • Status Date
    December 10, 2024
    a year ago
  • Published for Opposition Date
    February 13, 2024
    2 years ago
  • Location Date
    November 19, 2024
    a year ago
  • First Use Anywhere Date
    January 29, 2024
    2 years ago
  • First Use In Commerce Date
    January 29, 2024
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SANCHEZ RIVERA, MARIA
  • Attorney Docket Number
    RC1923
    Attorney Name
    xionghui murong
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
3
Mark Identification
BIOFLUCISION
Case File Statements
  • DM0000: The mark consists of wording "BIOFLUCISION" in stylized font with an arc across the letter "B".
  • GS0051: Anticoagulants; Chemotherapeutics; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for Nucleic acid amplification, analysis and labeling; Chemical reagents for medical or veterinary purposes; Clinical medical reagents for processing human whole blood and its components for use in blood transfusions stored in bags, bottles, syringes and other such containers used to store such substances in the medical field; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Enzymes for medical purposes; Medical diagnostic reagents; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pharmaceutical preparations, namely, anticoagulants; Preparations for detecting genetic predispositions for medical purposes; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Reagent paper for medical purposes; Reagents for medical use
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 4/13/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/2/2024 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/4/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/5/2023 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 1/10/2024 - 2 years ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/24/2024 - 2 years ago
    6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/13/2024 - 2 years ago
    7 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/13/2024 - 2 years ago
    8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/9/2024 - a year ago
    9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/30/2024 - a year ago
    12 - USE AMENDMENT FILED Type: IUAF
  • 8/30/2024 - a year ago
    10 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 10/31/2024 - a year ago
    11 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/19/2024 - a year ago
    15 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 11/19/2024 - a year ago
    14 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 12/10/2024 - a year ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/10/2024 - a year ago
    17 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/31/2024 - a year ago
    13 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC